Back to top

FDA Issues Warning Letter to Amphastar Subsidiary IMS

Amphastar Pharmaceuticals ( ($AMPH) ) just unveiled an update. On July 2, 2026, Amphastar’s subsidiary International Medication Systems received a ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Amphastar Pharmaceuticals, Inc. (AMPH)